Welcome to our dedicated page for U S Physical Therapy SEC filings (Ticker: USPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how clinic visit volumes, payer mix, and therapist partnership incentives shape U.S. Physical Therapy’s cash flow can feel overwhelming. When reimbursement tables are buried deep inside a 300-page report, even seasoned analysts struggle to find answers—especially if they just want U.S. Physical Therapy SEC filings explained simply.
StockTitan solves that problem. Our AI reads every U.S. Physical Therapy annual report 10-K simplified, flags changes in segment margins inside each U.S. Physical Therapy quarterly earnings report 10-Q filing, and streams U.S. Physical Therapy Form 4 insider transactions real-time. Need context on an unexpected acquisition? We surface the corresponding U.S. Physical Therapy 8-K material events explained alongside plain-English summaries. Prefer raw numbers? Download exhibits without digging through EDGAR.
- Instant alerts for U.S. Physical Therapy insider trading Form 4 transactions
- Side-by-side comparison of clinic metrics across quarters—perfect for U.S. Physical Therapy earnings report filing analysis
- Highlights of salary, bonus, and option grants pulled from the latest U.S. Physical Therapy proxy statement executive compensation
- Contextual pop-ups that make understanding U.S. Physical Therapy SEC documents with AI effortless
Whether you’re monitoring U.S. Physical Therapy executive stock transactions Form 4 before a new clinic rollout or checking covenant compliance after a debt refinancing, our real-time feed and AI-powered summaries give you the insight you need—without wading through endless footnotes.
U.S. Physical Therapy, Inc. (USPH) received a Schedule 13G from Copeland Capital Management, LLC disclosing beneficial ownership of 843,981 shares, representing 5.54% of the common stock as of 09/30/2025.
The filer reports sole voting power over 551,532 shares, shared voting power over 144,267 shares, sole dispositive power over 0 shares, and shared dispositive power over 843,981 shares. The reporting person is classified as an investment adviser (IA). The certification and signature were provided by Sofia A. Rosala, General Counsel and CCO.
Nancy Ham, a director of U S Physical Therapy, reported selling 600 shares of the company's common stock on 09/11/2025 at $81.71 per share. After the sale she beneficially owns 1,994 shares in total. That total includes 941 restricted shares granted under the company's Amended and Restated 2003 Stock Incentive Plan, with 470 shares scheduled to lapse (vest) on November 20, 2025 and 471 shares scheduled to lapse on March 6, 2026, subject to her continuing service as a director on those dates.
US Physical Therapy Inc (USPH) Form 144 notice: The filing reports a proposed sale of 600 shares of Common stockaggregate market value of $49,026, planned for approximately 09/11/2025 on the NYSE. The shares were acquired by vesting: 1,653 shares vested on 08/20/2025 from restricted stock grants issued between 05/16/2023 and 05/20/2025, with the acquisition characterized as payment for services rendered. The filing also discloses a prior sale of 400 shares on 06/12/2025 by Nancy Ham, generating $31,204 in gross proceeds. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Eric Joseph Williams, President and COO of U S Physical Therapy, reported a sale of 1,000 shares of the company’s common stock on 09/05/2025 at $85.25 per share. After the sale he beneficially owns 25,331 shares, which include 18,210 restricted shares subject to a multi-year vesting schedule if he remains an employee. The restricted shares vest in tranches between November 20, 2025 and March 6, 2029 as specified in the filing. The Form 4 was signed by an attorney-in-fact on 09/08/2025.
USPH Form 4: Christopher J. Reading, Chairman and CEO of U S Physical Therapy Inc (USPH), reported a single transaction on 09/04/2025 selling 2,000 shares of the issuer's common stock at a price of $83.53 per share. After the sale he beneficially owns 114,088 shares in total. The filing discloses that 34,098 of those shares were granted as restricted stock under the companys Amended and Restated 2003 Stock Incentive Plan, with a detailed vesting schedule listing tranche dates and share counts through March 6, 2029, contingent on continued employment.
US Physical Therapy, Inc. (USPH) reported a proposed sale of 1,000 common shares through Rule 144 to be executed on 09/05/2025 on the NYSE via Morgan Stanley Smith Barney LLC. The shares were acquired on 07/01/2024 under the company's Employee Stock Purchase Plan and were paid as compensation. The notice lists an aggregate market value of $85,250.00 for the shares and shows 15,204,119 shares outstanding for the issuer. The filer certifies they are unaware of undisclosed material adverse information and indicates no reportable securities sales in the past three months.
US Physical Therapy, Inc. (USPH) submitted a Form 144 notifying a proposed sale of 2,000 shares of common stock through UBS Financial Services on the NYSE with an aggregate market value of $165,127.20. The shares were originally acquired as restricted stock grants on 04/01/2020 (3,089 shares acquired) and were paid as compensation on the acquisition date. The filing states there were no securities sold by the reporting person in the past three months. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
US Physical Therapy Inc. (USPH) Chief Financial Officer Carey P. Hendrickson reported a disposal of 698 shares of common stock on 08/25/2025 at an average price of $86.11 per share, leaving beneficial ownership of 27,808 shares. The filing shows Mr. Hendrickson is an officer (Chief Financial Officer) and the Form 4 was filed by one reporting person.
The reported holdings include 14,510 shares issued as restricted stock under the companys Amended and Restated 2003 Stock Incentive Plan. Those restricted shares vest in scheduled tranches from November 20, 2025 through March 6, 2029, contingent on continued employment, with specific share counts and vesting dates provided in the filing.
US Physical Therapy, Inc. (USPH) filed a Form 144 proposing the sale of 700 shares of common stock through Charles Schwab & Co., Inc. The filing lists an approximate sale date of 08/25/2025 and reports an aggregate market value of $60,119. It shows total shares outstanding of 15,204,119, indicating the proposed sale represents a very small fraction of the companys outstanding stock. The shares were acquired on 01/01/2025 as employee equity compensation (1,208 shares reported acquired). The filer reports no sales in the past three months.
US Physical Therapy, Inc. insider sale reported. The company's COO and director, Graham D. Reeve, reported the sale of 763 shares of Common Stock on 08/21/2025 at a weighted average price of $84.97 per share. After the sale he beneficially owns 21,483 shares directly and 1,808 shares indirectly through the Reeve Trust. The filing notes that 15,296 of his shares are restricted stock with a detailed vesting schedule from November 2025 through March 2029.
FAQ
What is the current stock price of U S Physical Therapy (USPH)?
What is the market cap of U S Physical Therapy (USPH)?
